Anticoagulation may be beneficial in high risk factor V Leiden carriers.
Baglin
T
T
Baglin
C
C
Brown
K
K
Luddington
R
R
D000925:Anticoagulants / Q000627:therapeutic use*; D015331:Cohort Studies; D005165:Factor V / Q000235:genetics*; D006579:Heterozygote; D006801:Humans; D011446:Prospective Studies; D012008:Recurrence; D013924:Thrombophlebitis / Q000188:drug therapy; D014859:Warfarin / Q000627:therapeutic use*
D000925:Anticoagulants; C095381:factor V Leiden; D014859:Warfarin; D005165:Factor V